Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients

Hepatitis C Virus (HCV) infection treatment has dramatically changed with the advent of direct-acting antiviral agents (DAAs). However, the efficacy of DAAs can be attenuated by the presence of resistance-associated substitutions (RASs) before and after treatment. Indeed, RASs detected in DAA treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldunate, Fabián, Echeverría, Natalia, Chiodi, Daniela, López, Pablo, Sánchez-Cicerón, Adriana, Fajardo, Alvaro, Soñora, Martín, Cristina, Juan, Hernández, Nelia, Moreno, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112080/
https://www.ncbi.nlm.nih.gov/pubmed/30186532
http://dx.doi.org/10.1155/2018/2514901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112080/
https://www.ncbi.nlm.nih.gov/pubmed/30186532
http://dx.doi.org/10.1155/2018/2514901

Ejemplares similares